Literature DB >> 25101885

Seeking help: B cells adapting to flu variability.

Robbert G van der Most1, François P Roman2, Bruce Innis3, Emmanuel Hanon2, David W Vaughn2, Paul Gillard2, Karl Walravens2, Martine Wettendorff2.   

Abstract

The study of influenza vaccines has revealed potential interactions between preexisting immunological memory and antigenic context and/or adjuvantation. In the face of antigenic diversity, the process of generating B cell adaptability is driven by cross-reactive CD4 memory cells, such as T follicular helper cells from previous infections or vaccinations. Although such "helped" B cells are capable of adapting to variant antigens, lack of CD4 help could lead to a suboptimal antibody response. Collectively, this indicates an interplay between CD4 T cells, adjuvant, and B cell adaptability.
Copyright © 2014, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25101885     DOI: 10.1126/scitranslmed.3008409

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  11 in total

Review 1.  Can immunological principles and cross-disciplinary science illuminate the path to vaccines for HIV and other global health challenges?

Authors:  Christopher B Wilson; Christopher L Karp
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-06-19       Impact factor: 6.237

2.  Investigating the effect of AS03 adjuvant on the plasma cell repertoire following pH1N1 influenza vaccination.

Authors:  J D Galson; J Trück; D F Kelly; R van der Most
Journal:  Sci Rep       Date:  2016-11-16       Impact factor: 4.379

Review 3.  AS03- and MF59-Adjuvanted Influenza Vaccines in Children.

Authors:  Amanda L Wilkins; Dmitri Kazmin; Giorgio Napolitani; Elizabeth A Clutterbuck; Bali Pulendran; Claire-Anne Siegrist; Andrew J Pollard
Journal:  Front Immunol       Date:  2017-12-13       Impact factor: 7.561

4.  A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice.

Authors:  Raffael Nachbagauer; David Kinzler; Angela Choi; Ariana Hirsh; Edith Beaulieu; Nicolas Lecrenier; Bruce L Innis; Peter Palese; Corey P Mallett; Florian Krammer
Journal:  NPJ Vaccines       Date:  2016-09-22       Impact factor: 7.344

5.  Long-Term Persistence of Cell-Mediated and Humoral Responses to A(H1N1)pdm09 Influenza Virus Vaccines and the Role of the AS03 Adjuvant System in Adults during Two Randomized Controlled Trials.

Authors:  Robbert G van der Most; Frédéric Clément; Julie Willekens; Walthère Dewé; Karl Walravens; David W Vaughn; Geert Leroux-Roels
Journal:  Clin Vaccine Immunol       Date:  2017-06-05

Review 6.  Immune History and Influenza Vaccine Effectiveness.

Authors:  Joseph A Lewnard; Sarah Cobey
Journal:  Vaccines (Basel)       Date:  2018-05-21

Review 7.  "World in motion" - emulsion adjuvants rising to meet the pandemic challenges.

Authors:  Derek T O'Hagan; Robbert van der Most; Rushit N Lodaya; Margherita Coccia; Giuseppe Lofano
Journal:  NPJ Vaccines       Date:  2021-12-21       Impact factor: 7.344

Review 8.  New Insights into the Generation of CD4 Memory May Shape Future Vaccine Strategies for Influenza.

Authors:  Priyadharshini Devarajan; Bianca Bautista; Allen M Vong; Karl Kai McKinstry; Tara M Strutt; Susan L Swain
Journal:  Front Immunol       Date:  2016-04-11       Impact factor: 7.561

Review 9.  The Role of CD4 T Cell Memory in Generating Protective Immunity to Novel and Potentially Pandemic Strains of Influenza.

Authors:  Anthony DiPiazza; Katherine A Richards; Zackery A G Knowlden; Jennifer L Nayak; Andrea J Sant
Journal:  Front Immunol       Date:  2016-01-25       Impact factor: 7.561

Review 10.  Sustainable vaccine development: a vaccine manufacturer's perspective.

Authors:  Rino Rappuoli; Emmanuel Hanon
Journal:  Curr Opin Immunol       Date:  2018-05-08       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.